Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 79925 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondents Form name Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Total ........................................... ........................................................... ........................ ........................ ........................ 2,334 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–22475 Filed 9–30–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–24–24IV; Docket No. CDC–2024– 

0071] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled 

‘‘Comprehensive Evaluation of the 

Implementation and Uptake of the CDC 

Clinical Practice Guideline for 

Prescribing Opioids for Pain’’. This data 

collection is designed to allow CDC to 

evaluate the 2022 CDC Clinical Practice 

Guidelines for opioid prescription 

practices. 

DATES: CDC must receive written 

comments on or before December 2, 

2024. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2024– 

0071 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, H 

21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Comprehensive Evaluation of the 

Implementation and Uptake of the CDC 

Clinical Practice Guideline for 

Prescribing Opioids for Pain—New— 

National Center for Injury Prevention 

and Control (NCIPC), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

Beginning in the 1990s, opioid 

prescribing rates for pain management 

steadily increased until 2010, remained 

steady until 2012, and have declined 

since then. The increase in opioid 

prescribing rates corresponded with 

increases in opioid-involved overdose 

deaths, which initially primarily 

involved prescription opioids (natural 

and semi-synthetic opioids and 

methadone). In response to this 

emerging crisis, CDC issued the CDC 

Guideline for Prescribing Opioids for 

Chronic Pain—United States, 2016 

(2016 CDC Guideline). Implementing 

the 2016 CDC Guideline was associated 

with reductions in opioid prescribing 

and increases in use of non-opioid 

medications for pain. At the same time, 

laws and policies related to prescribing 

opioids were instituted that misapplied 

or were inconsistent with the 2016 CDC 

Guideline, potentially contributing to 

patient harm. In 2022, CDC released the 

CDC Clinical Practice Guideline for 

Prescribing Opioids for Pain—United 

States, 2022, which provided up to date 

evidence regarding pain management 

approaches and re-emphasizes the need 

for prescribers to be focused on patientcentered care to provide effective pain 

management. CDC is comprehensively 

evaluating the uptake, implementation, 

and outcomes of the 2022 CDC Clinical 

Practice Guideline on evidence-based 

care for pain management to understand 

its impact. 


khammond on DSKJM1Z7X2PROD with NOTICES
79926 Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices 

To meet CDC’s goal for a rigorous, 

comprehensive evaluation, this 

collection is proposing a mixed-method 

quasi-experimental design with the 

following three aims to evaluate the 

2022 CDC Clinical Practice Guideline: 

• Aim 1: Dissemination—Assess 

CDC’s efforts in disseminating the 2022 

CDC Clinical Practice Guideline. 

• Aim 2: Impact—Evaluate the impact 

of the 2022 CDC Clinical Practice 

Guideline through population-wide 

changes in prescribing practices for 

opioids and medications for opioid use 

disorder. 

• Aim 3: Implementation—Evaluate 

the implementation of the 2022 CDC 

Clinical Practice Guideline from 

perspectives of patients, caregivers, 

clinicians; and leaders from health 

systems, payers, professional 

associations, and medical boards. 

This evaluation will include 

systematic collection and analysis of a 

range of primary and secondary data 

sources. To answer the research 

questions, we will employ qualitative 

synthesis and analytic approaches, 

quantitative analyses, and various 

mixed-methods approaches. Primary 

data collection efforts include a webbased survey conducted among a 

national sample of clinicians, virtual 

interviews with clinicians, virtual 

interviews with dentists, virtual 

interviews with leaders from 

professional organizations, payers, 

medical boards, and health systems, and 

virtual focus groups with patients and 

caregivers. 

The CDC will use this information 

collection to evaluate the dissemination, 

impact, and implementation of the 2022 

CDC Clinical Practice Guideline to 

ensure that Americans have access to 

safer, effective ways of managing their 

pain. CDC requests OMB approval for an 

estimated 325 annual burden hours. 

There is no cost to respondents other 

than their time. 

Estimated Annualized Burden Hours 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Clinicians ........................................... Clinician Survey ............................... 200 1 10/60 33 

Invitation ........................................... 1,000 1 5/60 83 

Follow up Emails .............................. 1,000 1 5/60 83 

Clinician Interview ............................ 10 1 1 10 

Dentists ............................................. Dentist Interview ............................... 2 1 1 2 

Health System Leaders .................... Health System Leaders Interview .... 3 2 1 6 

Payers ............................................... Payer Interview ................................ 3 2 1 6 

Professional Association Leaders ..... Professional Association Leaders 

Interview.

3 2 1 6 

Medical Board Leaders ..................... Medical Board Leaders Interview .... 3 2 1 6 

Patients ............................................. Patient Focus Groups ...................... 15 3 1 45 

Caregivers ......................................... Caregiver Focus Groups .................. 15 2 1 30 

Total ........................................... ........................................................... ........................ ........................ ........................ 325 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2024–22474 Filed 9–30–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–24–24AL] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Occupational 

Exposures to Surgical Smoke in 

Veterinary Personnel’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on November 

3, 2023 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Occupational Exposures to Surgical 

Smoke in Veterinary Personnel—New— 

National Institute for Occupational 


khammond on DSKJM1Z7X2PROD with NOTICES